CharooNA; Succor Pharma Solutions, Dubai Science Park, Dubai, United Arab Emirates.; Cenric Compounding LLC, Dubai Science Park, Dubai, United Arab Emirates.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2022 Oct; Vol. 21 (10), pp. 4133-4145. Date of Electronic Publication: 2022 Jan 12.
Selective laser sintering 3D printing - an overview of the technology and pharmaceutical applications.
Autorzy:
CharooNA; Zeino Pharma FZ LLC, 703-HQ Complex-North Tower, Dubai, United Arab Emirates. Barakh Ali SF; Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Texas A&M University, College Station, TX, USA. Mohamed EM; Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Texas A&M University, College Station, TX, USA.; Department of Pharmaceutics, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Kuttolamadom MA; Engineering Technology & Industrial Distribution, College of Engineering, Texas A&M University, College Station, TX, USA. Ozkan T; Dover Precision Components, Woodlands, TX, USA. Khan MA; Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Texas A&M University, College Station, TX, USA. Rahman Z; Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Texas A&M University, College Station, TX, USA.
Integrating biopharmaceutics risk assessment and in vivo absorption model in formulation development of BCS class I drug using the QbD approach.
Autorzy:
CharooNA; a Zeino Therapeutics , Khalifa Industrial Zone , Abu Dhabi , United Arab Emirates. Cristofoletti R; b Division of Therapeutic Equivalence , Brazilian Health Surveillance Agency (ANVISA) , Brasilia , Brazil.; c Institute of Pharmaceutical Technology, Goethe University , Frankfurt am Main , Germany. Kim SK; d QbD Works LLC , Fremont , CA , USA.
Pharmaceutical product development: A quality by design approach.
Autorzy:
Pramod K; College of Pharmaceutical Sciences, Government Medical College, Kozhikode, Kerala, India. Tahir MA; Biogenero Labs Pvt Ltd., Unit No.1, Sy. No 179, C.K Palya, Hullahalli, Sakalvara Post, Bangalore, India. CharooNA; Zayn Pharmaceuticals, Unit No. 2H-05-320, Floor No.5 Bldg No.2, Plot No. 550-554 J&G, DMCC, Dubai, United Arab Emirates; AlFalah Life Sciences Pvt. Ltd. 27-Wathora, Budgam-191113, Jammu and Kashmir, India. Ansari SH; Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi, India. Ali J; Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi, India.
Pediatric drug development: formulation considerations.
Autorzy:
Ali AA; Department of Clinical Pharmacy and Pharmacology, RAKCOPS, RAK Medical and Health Sciences University , Ras Al Khaimah , UAE . CharooNA Abdallah DB
Transdermal delivery of flurbiprofen: permeation enhancement, design, pharmacokinetic, and pharmacodynamic studies in albino rats.
Autorzy:
CharooNA; Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, TA 11/1, Gali No. 1, Tughlaq Abad Ext., New Delhi 110019, India />Anwer A Kohli K Pillai KK Rahman Z
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
